Long-term concentrations of nitrogen dioxide and mortality: a meta-analysis of cohort studies. by Atkinson, RW et al.
460 | www.epidem.com Epidemiology • Volume 29, Number 4, July 2018
Background: Concentrations of outdoor nitrogen dioxide (NO2) 
have been associated with increased mortality. Hazard ratios (HRs) 
from cohort studies are used to assess population health impact 
and burden. We undertook meta-analyses to derive concentration–
response functions suitable for such evaluations and assessed their 
sensitivity to study selection based upon cohort characteristics.
Methods: We searched online databases and existing reviews for 
cohort studies published to October 2016 that reported HRs for NO2 
and mortality. We calculated meta-analytic summary estimates using 
fixed/random-effects models.
Results: We identified 48 articles analyzing 28 cohorts. Meta-analysis 
of HRs found positive associations between NO2 and all cause (1.02 
[95% confidence interval (CI): 1.01, 1.03]; prediction interval [PI]: 
[0.99, 1.06] per 10 µg/m3 increment in NO2), cardiovascular (1.03 
[95% CI: 1.02, 1.05]; PI: [0.98, 1.08]), respiratory (1.03 [95% CI: 
1.01, 1.05]; PI: [0.97, 1.10]), and lung cancer mortality (1.05 [95% CI: 
1.02, 1.08]; PI: [0.94, 1.17]) with evidence of substantial heterogeneity 
between studies. In subgroup analysis, summary HRs varied by age at 
cohort entry, spatial resolution of pollution estimates, and adjustment 
for smoking and body mass index at the individual level; for some sub-
groups, the HR was close to unity, with lower confidence limits below 1.
Conclusions: Given the many uncertainties inherent in the assess-
ment of this evidence base and the sensitivity of health impact 
calculations to small changes in the magnitude of the HRs, calcula-
tion of the impact on health of policies to reduce long-term exposure 
to NO2 should use prediction intervals and report ranges of impact 
rather than focusing upon point estimates.
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Epidemiologic studies have reported associations between long-term concentrations (typically averaged over a year or 
more) of outdoor air pollution and a range of health end points. 
Outdoor air pollution comprises a mixture of particles and 
gases, emitted directly from the combustion of fossil fuels or 
formed from secondary chemical reactions in the air. The evi-
dence for ambient particulate matter monitored as PM2.5 (mass 
per m3 of particles of aerodynamic diameter generally less than 
2.5 µm) has been extensively reviewed and judged sufficient to 
infer a causal, adverse effect on a range of health outcomes.1,2
Nitrogen dioxide (NO2) is a respiratory toxicant gas 
which in outdoor air is derived primarily from the oxidation 
of nitric oxide (NO). In urban areas, the predominant source 
of NO and NO2, as well as carbon particles, carbon monox-
ide, and other pollutants, is motor vehicle exhaust. A grow-
ing number of cohort studies have exploited spatial variability 
in long-term NO2 concentrations estimated using pollution 
models based upon the interpolation of monitoring data, land-
use regression, or dispersion models3 to investigate associa-
tions with mortality or disease incidence. Recent systematic 
reviews and meta-analyses have assessed the evidence from 
cohort studies published to 2013–2014 and reported asso-
ciations between NO2 concentrations and mortality from all-
cause, cardiovascular, and respiratory diseases4,5 and lung 
cancer.6 An assessment of the evidence for oxides of nitro-
gen conducted by the US Environmental Protection Agency 
Integrated Science Assessment7 including toxicologic and 
epidemiologic evidence across a wide range of health end 
points concluded that “the evidence is suggestive of, but not 
sufficient to infer, a causal relationship between long-term 
exposure to NO2 and mortality among adults.” This extensive 
review included cohort studies published up to 2014 but did 
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not undertake meta-analyses nor attempt to establish concen-
tration–response functions for use in health impact calcula-
tions. A similar conclusion was reached by Health Canada 
following their review.8
Summary risk estimates [hazard ratios (HRs)] from 
meta-analyses of cohort studies are used in policy evaluations 
to assess the health impact and burden of current, and future, 
pollutant concentrations.9 These calculations usually apply to 
the general population of a defined geographical area, and the 
results are often widely reported/discussed in the mainstream 
media outlets. In air pollution epidemiology, HRs are gener-
ally small (close to 1) indicating low individual risk. How-
ever, because of the ubiquitous nature of ambient air pollution 
and the very large populations exposed, small HRs can trans-
late into important, and substantial, consequences for health 
at the population level. The process used to derive the sum-
mary HRs, including decisions on included studies, appropri-
ate analytical model, assessment of heterogeneity, and effect 
modification, are therefore important.
In this study, we undertook a systematic search of the 
literature to identify cohort studies examining the associa-
tion between long-term concentrations of NO2 and mortality. 
We used stratified meta-analyses to assess the sensitivity of 
summary HRs to the selection of studies with different cohort 
and study characteristics and considered the implications for 
the selection of concentration–response functions for use in 
health impact assessment in a general population. We also cal-
culated prediction intervals and considered their relevance for 
health impact assessment exercises. Our study updates previ-
ous reviews by including studies published to October 2016 
and incorporating a wider range of causes of death.
METHODS
To identify publications reporting results from cohort 
studies of NO2 and mortality, we conducted a broad search 
of the online medical databases supplemented with citation 
searches of recently published literature reviews.
Search Strategy
We applied the search string “cohort & (‘no2’ or ‘nitro-
gen dioxide’ or ‘air pollution’) & mortality” to: (1) Ovid 
Medline (R) without Revisions for the period 1996 to Octo-
ber Week two 2016 and Embase for the period 1996 to 2016 
Week 42; (2) Web of Science (1970 to October 2016); and (3) 
Pubmed (1966 to October 2016). We also searched citations 
in five review articles.4–6,10,11 Studies identified in each search 
were combined and duplicates removed leaving 959 studies to 
be assessed.
Inclusion/Exclusion Criteria
Studies were screened by study title and abstract. Inclu-
sion criteria were (1) cohort studies including individual-level 
covariate information; and (2) a “long-term” exposure metric 
for NO2, i.e., annual or multi-year averages. Exclusion crite-
ria were (1) conference abstracts, conference papers, notes, 
editorials, and letters; (2) cross-sectional, case–control and 
nested case–control study designs; (3) mean daily or monthly 
NO2 exposure metrics (short-term exposure [time series] stud-
ies); and (4) study population selected because of close prox-
imity to specific pollution sources (e.g., waste incinerators). 
After applying these inclusion/exclusion criteria, 73 studies 
remained and were subject to full-text review.
Suitability of these studies for inclusion in the quan-
titative assessment was assessed as follows: studies were 
excluded if (1) they reported results for NOX rather than NO2 
(n = 5); (2) replicated results from previous publications 
(n = 7); or (3) did not provide quantitative HRs together with 
a measure of precision (standard errors or 95% confidence 
intervals) and adequate information to enable standardization 
of the HR per 10 µg/m3 increase in NO2 (n = 13). Forty-eight 
studies remained from which data characterizing the outcome, 
HR, and other relevant information were extracted. Figure 1, 
adapted from Moher et al,12 summarizes the literature search 
and study assessment.
Data Extraction and Coding
We extracted cohort and estimate level information from 
each paper and entered it into an EXCEL database. These 
data included cohort name, country, cohort description, date 
of enrolment of cohort members, age at enrollment, number 
of subjects, follow-up period, exposure period, and exposure 
assessment method (measured/modeled). The level of covari-
ate adjustment was also recorded including individual-level 
age, sex, smoking, and body mass index (BMI) and level of 
adjustment for a marker of socioeconomic status (e.g., educa-
tion level, income, etc.) at either the individual or ecologic 
level. All HRs were standardized to 10 µg/m3 increase in NO2. 
Where the units used in the original study were ppb, a conver-
sion factor of 1.88 µg/m3 per 1 ppb was used (assuming 25°C 
and 1013 mb atmospheric pressure).
Meta-analysis
Where studies reported results for various follow-up 
periods for the same cohort, we selected studies using the 
most recent follow-up period. If results for the same outcomes 
were available for the full cohort and a subset, we used results 
from the full cohort unless these results were considered to be 
out of date (e.g., statistical analysis, exposure assessment, date 
of last follow-up). Two studies from the same cohort were only 
included if they provided results for different outcomes.
We conducted analyses in STATA Version 12 (Stata-
Corp. 2011). All studies reported HRs together with 95% 
confidence intervals. Therefore, estimates of the standard 
error were derived using each limit value and the two esti-
mates averaged. Forest plots were used to display study 
information and HRs graphically. Articles used different 
terms to describe causes of death and were grouped together 
for meta-analysis according to terms and International Clas-
sification of Diseases codes where available (eTable 1; http://
links.lww.com/EDE/B348). We calculated meta-analytic 
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summary estimates using fixed and random-effects models 
using the program “metan” in STATA and assessed hetero-
geneity using the I2 statistic. Prediction intervals were cal-
culated when heterogeneity was identified.13 Small study 
bias was assessed using Begg and Berlin14 and Egger et al15 
tests and the Trim and Fill procedure.16
A series of stratified analyses assessed potential effect 
modification by both cohort and study characteristics. Cohort 
characteristics included (1) study population—general popu-
lation cohorts versus cohorts using subjects with preexisting 
disease; and (2) age at recruitment, cohorts based upon adults 
across a wide age range at recruitment versus cohorts in selected 
ages at cohort entry. As the focus of our investigation was the 
identification of concentration–response functions for use in 
health impact assessments, we selected cohorts conducted in the 
general population and without narrow age restriction at cohort 
entry for further stratified analyses by study characteristics. 
These included (1) adjustment for individual measures of BMI 
and smoking versus no adjustment or use of area-level estimates 
of BMI and/or smoking; and (2) use of land-use regression 
models to estimate residential NO2 concentrations versus area-
based concentration estimates. Our evaluation of differences 
between strata was based upon the sizes and confidence inter-
vals of the respective summary HRs and the differences between 
HRs assessed using the method of Altman and Bland.17
RESULTS
The 48 articles identified in the review analyzed 
28 cohorts (including the European Study of Cohorts for Air 
Pollution Effects (ESCAPE) study comprising 22 separate 
cohorts).18–65 eTable 2; http://links.lww.com/EDE/B348 pro-
vides a description of each article/cohort including cohort 
size and geographical location, subject characteristics, expo-
sure assessment and control for key individual confounders. 
Cohorts were studied in Europe (13 including the ESCAPE 
consortium of cohorts), North America (10), Taiwan (1), 
China (2), and Japan (2).
HRs for NO2 and all-cause mortality were reported in 
32 studies (22 cohorts including ESCAPE) and cause-specific 
mortality in 41 studies (24 cohorts including ESCAPE).
FIGURE 1. Summary of literature search and 
study assessment. Adapted from PLoS Med. 
2009;6:e1000097.
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All-cause Mortality
Of the 32 studies reporting results for all-cause mortal-
ity (eFigure 1; http://links.lww.com/EDE/B348), 11 studies, 
selected according to our a priori algorithm, were excluded 
from the meta-analyses: 3 studies39,41,54 because their results 
were included in the ESCAPE meta-analysis21 and 8 studies as 
the same cohorts were analyzed in other publications included 
in our review.27,32,42,44,47,48,63,65 In one article,43 results for two 
cohorts were reported; we did not use the HR for the Ameri-
can Cancer Society Cancer Prevention Study-II (ACS CPS 
II) cohort reported in this study, but selected the more recent 
reanalyses of the ACS CPS II cohort61 instead. Following these 
exclusions, results from 20 separate cohorts (including the 
ESCAPE consortium of 22 individual cohorts) reported results 
for NO2 and all-cause mortality. In the fixed-effects meta-anal-
ysis (eFigure 2a; http://links.lww.com/EDE/B348), three large 
administrative cohorts26,31,36 and the ACS study61 accounted 
for 80% and 11% of the weight, respectively. Meta-analysis 
indicated a high level of heterogeneity between study HRs 
(I2 = 84%). The random-effects summary HR was 1.02 (95% 
confidence interval [CI]: 1.01, 1.03; prediction interval [PI]: 
0.99, 1.06) per 10 µg/m3 increment in NO2 (Table 1 and eFigure 
2b; http://links.lww.com/EDE/B348). Begg and Egger tests for 
small study bias returned P values of 0.3 and 0.9, respectively. 
Application of the trim and fill technique indicated the need 
to impute two additional study estimates to adjust for small 
study bias assuming a fixed random-effects model although the 
adjusted HR (and 95% CI) remained unchanged.
Five studies investigated associations with mortality 
in cohorts selected on the basis of preexisting disease: survi-
vors of stroke,51 coronary heart disease,56 acute coronary syn-
drome,59 attendees at respiratory clinic,45 and hypertensive US 
veterans49 (eFigure 3; http://links.lww.com/EDE/B348). Meta-
analysis of these studies gave a summary HR of 1.04 per 10 
μg/m3 increment in NO2 compared with 1.02 for the 15 cohorts 
recruiting subjects from the general population (Table 1).
Eleven of the 15 cohorts recruited adults within a broad 
age range and four cohorts limited recruitment to narrower age 
ranges: 35–50,23 55–69 years,24 25–59 years,35 and 65–84 years 
of age62 (eFigure 4; http://links.lww.com/EDE/B348). A strati-
fied meta-analysis indicated a substantial difference in the sum-
mary HRs between cohorts recruiting adults over a broad age 
range compared with cohorts restricting age at entry, 1.02 ver-
sus 1.08 per 10 μg/m3 increment in NO2, respectively (Table 1).
For the 11 cohorts that recruited adults within a 
broad age range, Figure 2 shows the cohort-specific HRs 
and meta-analytic summary estimates stratified by (1) level 
of covariate adjustment, i.e., those controlling for required 
confounding factors including individual BMI and smok-
ing status and those who did not; (2) the spatial resolution 
TABLE 1. Summary HRs (95% CI) for All-cause Mortality Without and With Stratification by Selected Study Characteristics
Cohort Stratification
No.  
Cohorts
HR (95% CI)  
per 10 µg/m3 I2 (%) Pa Figureb
All Cohorts n = 32 (Removed = 12) e1
Cohorts excluding duplicates  
  Selected cohortsc Fixed 20 1.03 (1.02, 1.03) 84 NA e2a
Random 1.02 (1.01, 1.03) 
(0.99, 1.06)d
e2b
Stratification by cohort characteristics  
  Preexisting disease Yes 5 1.04 (0.98, 1.10) 76 0.82 e3
No 15 1.02 (1.01, 1.03) 86
Stratification by cohort characteristics  
excluding preexisting disease cohorts
  Age-restrictedc,e Yes 4 1.08 (1.02, 1.15) 79 0.04 e4
No 11 1.02 (1.01, 1.03) 88
Stratification by study characteristics excluding  
preexisting disease and age-restricted cohorts
  Individual BMI and smoking adjustmentc,e,f Yes 7 1.00 (0.98, 1.03) 89 0.03 2A
No 4 1.03 (1.02, 1.04) 67
  Residential NO2 exposure estimates
c,e,f Yes 6 1.03 (1.02, 1.03) 67 0.19 2B
No 5 1.00 (0.96, 1.04) 90
aP value for differences in summary hazard ratios.
bCorresponding figure giving study information.
cExcluding studies identified as previous/smaller analyses of the same cohort and cohorts included in ESCAPE.
dPrediction interval.
eExcluding preexisting disease cohorts.
fExcluding age-restricted cohorts.
NA indicates not applicable
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FIGURE 2. (Continued)
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of the estimated NO2 concentrations, i.e., land-use regres-
sion models predicting concentrations at subjects’ residen-
tial addresses versus estimates for larger geographical areas 
derived from models or interpolation of data from monitor-
ing stations; and (3) ordered by study mean/median NO2 
concentration. HRs from studies that controlled for indi-
vidual measures of BMI and smoking were more variable 
and less precise than HRs from studies lacking this level of 
covariate adjustment. Summary HRs for the two subgroups 
are presented in Table 1 and indicate a larger summary HR 
(P = 0.03) for studies without control for individual mea-
sures of BMI and smoking compared with studies that did 
(1.03 vs. 1.00 per 10 μg/m3 increment in NO2). Studies that 
used estimated area-level concentrations of NO2 were more 
variable and less precise than studies that used land-use 
regression-based residential concentration estimates and 
when meta-analyzed gave a smaller summary HR (1.00) 
compared with studies using residential land-use regres-
sion estimates (1.03). Three administrative cohorts con-
structed from national registries rather than recruitment 
of individuals accounted for 3/4 studies that did not adjust 
for individual-level BMI and smoking and 3/6 studies that 
used residential concentration estimates from land-use 
regression models. When ordered by study mean/median 
NO2 concentration (Figure 2C), there was a suggestion of 
a downward trend in the size of the HR as study mean NO2 
concentrations increased. Meta-regression confirmed this 
impression (data not shown).
Cause-specific Mortality
Cardiovascular
Twenty-two studies reported results for cardiovascular 
mortality (eFigure 5; http://links.lww.com/EDE/B348). Two 
studies54,57 were excluded from the meta-analyses as their 
results were included in the ESCAPE meta-analysis22 and four 
studies were excluded as the same cohorts were analyzed in 
other publications included in our review.20,32,44,63 One study 
from China64 reported a (precisely estimated) HR in excess of 
2.4 per 10 µg/m3 increment in NO2. The authors were cautious 
about the validity of this extreme finding in the Shenyang 
cohort, and therefore, the study was excluded from further 
analyses.
The random-effects summary HR for the remaining 15 
studies was 1.03 (95% CI: 1.02, 1.05; PI: 0.98, 1.08) per 10 
µg/m3 increment in NO2 (Table 2). Heterogeneity between-
study estimates was high (83%). No evidence of small study 
bias was detected (data not shown). After exclusion of the 
age-restricted cohorts, larger summary HRs were observed 
in studies with limited age ranges at cohort enrolment (vs. 
broader age ranges); in cohorts without individual adjust-
ment for BMI and smoking (vs. studies with individual 
adjustment); and in studies using residential land-use 
FIGURE 2. (Continued). HRs for all-cause mortality stratified by: A, level of adjustment for smoking and BMI; (B) spatial resolution 
of NO2 concentration estimates; (C) study mean/median NO2 concentrations. ES - Hazard ratio; CanCHEC – Canadian Census 
Health and Environment Cohort; DUELS – Dutch Environmental Longitudinal Study; CTS – California Teachers Society; ASHMOG 
- Adventist Health Study of Smog; CPRD – Clinical Practice Research Database; LUR Land Use Regression.
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regression estimates (compared to area-level concentrations 
of NO2; Table 2).
Respiratory
Of the 18 studies reporting HRs for respiratory mortal-
ity (eFigure 21; http://links.lww.com/EDE/B348), five were 
excluded from the meta-analysis (included in the ESCAPE 
study41; analyzed in other publications included in the 
review32,44,63; and the Chinese Shenyang cohort study34 which 
reported an HR of 2.97 per 10 µg/m3 increment in NO2). The 
random-effects summary HR (13 studies) was 1.03 (95% CI: 
1.01, 1.05; PI: 0.97, 1.10) per 10 µg/m3 increment in NO2. 
Heterogeneity between study estimates was high (I2 = 76%). 
Following exclusion of the two age-restricted cohorts, a larger 
summary HR was observed in cohorts without individual 
adjustment for BMI and smoking compared with those with 
individual adjustment (1.04 vs. 1.01 per 10 μg/m3 increment 
in NO2; P =0.001). A larger summary HR was also observed 
in studies using area-level concentrations of NO2 (compared 
with residential land-use regression estimates; Table 2).
Lung Cancer
Twenty studies reported results for lung cancer mor-
tality (eFigure 33; http://links.lww.com/EDE/B348). Four 
studies, selected according to our a priori algorithm, were 
excluded as the same cohorts were analyzed in other publica-
tions included in the review.43,44,47,63 In the fixed-effects meta-
analysis, two large administrative cohorts31,36 and the ACS 
study61 accounted for over 80% of the weight. Heterogeneity 
between study HRs was high (I2 = 88%). The random-effects 
summary HR for the 16 studies was 1.05 (95% CI: 1.02, 1.08; 
PI: 0.94, 1.17) per 10 µg/m3 increment in NO2 (Table 2). There 
was no evidence of publication bias. After exclusion of the 
age-restricted cohorts, larger summary HRs were observed 
in studies with limited age ranges at cohort enrollment 
(vs. broader age ranges) and in cohorts without individual 
adjustment for BMI and smoking (vs. studies with individual 
adjustment; Table 2). Stratification by spatial resolution of the 
estimated NO2 concentrations suggested little difference in 
the respective summary HRs (Table 2 and eFigure 37; http://
links.lww.com/EDE/B348).
Other Causes
Sufficient studies were available for meta-analysis for 
coronary heart disease (CHD) (12), cerebrovascular (8), and 
chronic obstructive pulmonary disorder (COPD; 8) after 
exclusions. Details of exclusions are given in the supplemen-
tary material; http://links.lww.com/EDE/B348 and results are 
presented in Table 3. Summary HRs for CHD and COPD were 
1.05 and 1.03, respectively, but close to 1 for cerebrovascular 
mortality. Heterogeneity was also present except for COPD. 
For CHD, the summary HR observed for cohorts with indi-
vidual measures of BMI and smoking was the same as those 
without. A larger summary HR was observed in studies using 
estimates of residential versus small area NO2 concentrations 
for CHD but reversed for COPD.
Five studies (three from Japan, one from the United 
States, and one from England) analyzing four cohorts reported 
HRs for pneumonia mortality and NO2 (eFigure 32; http://
links.lww.com/EDE/B348). The meta-analytic summary HR 
(studies n = 4) was 1.08 (95% CI: 1.06, 1.09) with no evi-
dence of heterogeneity (I2 = 0%). Three studies31,55,61 in three 
cohorts (CanCHEC, DCH, and ACS) reported HRs for diabe-
tes-associated mortality giving a random-effects summary HR 
of 1.04 (95% CI: 1.00, 1.07) per 10 µg/m3 increment in NO2, 
respectively (eFigure 38; http://links.lww.com/EDE/B348). A 
single study based on data from the ACS52 reported a hazard 
ratio for brain cancer mortality of 0.93 (95% CI: 0.89, 0.98) 
per 10 µg/m3 increment in NO2.
DISCUSSION
Our study identified 48 articles reporting results for 
all-cause and cause-specific mortality from 28 cohorts. The 
majority of the cohorts were in North America and Europe 
with only a few cohorts in Asia. Concentrations of NO2 were 
positively associated with all-cause mortality and mortality 
from cardiovascular and respiratory diseases and lung cancer. 
Summary hazard ratios were generally in the range 1.02–1.5 
per 10 µg/m3 with lower confidence limits above 1. There was 
substantial heterogeneity between HRs for all categories of 
death except COPD and pneumonia mortality. There was evi-
dence of effect modification by subject age range at cohort 
recruitment and control for individual measures of smoking 
and BMI. Studies using cohorts comprising subjects with 
preexisting respiratory and cardiovascular disease tended to 
report higher HRs than the studies in the general population.
Our study adds to previous quantitative reviews by 
incorporating studies published to October 2016 and a wider 
range of cause-specific mortality. A review in 20144 included 
studies of NO2 and NOX published between 2004 and January 
2013 but was restricted to studies (n = 23) which also included 
HRs for particles. Hoek et al5 also reviewed studies published 
to January 2013 reporting results for NO2 and fine and coarse 
particles and carbon. Our study identified 20 cohort studies of 
NO2 and mortality published during the period 2013 to Octo-
ber 2016, an indication of the growing evidence base, though 
a number of these more recent studies included reanalyses of 
existing cohorts. Only seven of the 48 studies (five separate 
cohorts) identified were outside of North America and Europe 
and illustrated the limited geographical spread of the current 
evidence base. Nonetheless, the addition of new studies can 
facilitate meta-analysis of less common causes of death and 
incorporate results from updated cohorts with longer follow-
up periods, enhanced exposure estimation, or inclusion of new 
variables in the analyses. Therefore, ongoing review of studies 
remains appropriate.
Our summary HR for all-cause mortality (cohorts 
n = 20) 1.02 (95% CI: 1.01, 1.03) per 10 µg/m3 increment in 
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NO2 was smaller than reported in Faustini et al
4 (n = 12; 1.04 
[95% CI: 1.02, 1.06]) and Hoek et al5 (n = 11; 1.06 [1.04, 
1.08]). Because of the ubiquitous nature of ambient air pol-
lution and the very large populations exposed, small HRs can 
translate into substantial consequences for health at the pop-
ulation level. Hence, small variations in summary HRs can 
translate into important differences in population impact. The 
process used to derive the summary HRs therefore needs care-
ful consideration.
The selection of study results for meta-analysis depends 
upon which studies are identified (which in turn depends upon 
the search strategy, review period, inclusion/exclusion criteria, 
etc.) and the protocol for estimate selection and highlights the 
importance of preparing, a priori, an analytical protocol for 
study and estimate selection without reference to the direc-
tion and magnitude of the HRs. The choice of model, fixed or 
random, also needs consideration.66 In a fixed-effects model, a 
single underlying HR is assumed, whereas in a random-effects 
model, a distribution of HRs is assumed. For NO2, a fixed-
effects model would seem to be an appropriate a priori choice: 
NO2 does not vary in its composition from one location to 
another nor would one expect its toxicity to vary, unlike par-
ticulate matter. However, studies vary in many other respects 
including modeling of pollution concentrations, population 
characteristics, and statistical model/confounders, suggesting 
that a random effects is most appropriate. The two modeling 
approaches also differ in the assignment of study weights; 
a fixed-effects model assigns weights based upon the preci-
sion of study estimates, whereas a random-effects model also 
incorporates between-study variability. As a consequence, 
in a random-effects model, smaller studies are given larger 
weight in the meta-analysis. This may or may not be appro-
priate depending upon the characteristics of the studies. For 
example, smaller studies may have a greater range of indi-
vidual confounders and possibly higher data quality than very 
large studies based upon large administrative databases with 
limited data on individual risk factors. In such a scenario, the 
reweighting that can arise in a random-effects model may be 
appropriate.
In common with previous reviews,4,5 our study found 
high levels of heterogeneity between study HRs for almost 
all causes of death assessed. Heterogeneity is an indicator of 
the extent to which study estimates are sufficiently consistent 
to be summarized using a weighted average in a fixed-effects 
model. The presence of heterogeneity indicates that the vari-
ability between study estimates is too great to be explained 
by chance alone but it does not necessarily rule out a causal 
interpretation.67 Large variations in study size (as here where 
sample sizes ranged from 2000+ to 7.5 million) can lead to 
an artificially high I2 statistic, a measure of heterogeneity.68 
An investigation of the sources of this heterogeneity is needed 
to inform the interpretation of the evidence.69 Such an inves-
tigation also prevents these issues becoming lost in the sta-
tistical summary70 provided by a random-effects analysis.71 
The presence of high levels of heterogeneity between cohort 
estimates in our study is therefore an important finding in its 
own right and should be incorporated into any assessment of 
the evidence.
We assessed a range of potential effect modifiers. We 
first compared HRs from studies in subjects with preexist-
ing disease with other cohorts. For all-cause mortality, we 
observed a larger, less-precise summary HR in subjects with 
preexisting disease (1.04) versus the rest (1.02). This compari-
son was limited however in two ways: (1) the small number of 
studies; and (2) such cohorts tend to be smaller and therefore 
carry little weight in any meta-analyses. Inclusion or other-
wise in a meta-analysis should not be guided by a statistical 
assessment of differences between HRs; rather, it should be 
determined by the purpose of the analysis—hazard identifica-
tion or calculation of a concentration–response function for 
input to a health impact calculation in the general population. 
To assess other potential effect modifiers, we chose to exclude 
studies in subjects with preexisting disease. Sensitivity analy-
ses including these cohorts did not alter materially our find-
ings (data not shown).
A small number of studies23,24,35,62,63 used restricted age 
ranges for subjects at cohort entry limiting our ability to com-
pare their results with cohorts including subjects with broad 
adult age ranges on entry. There was a tendency for cohorts 
restricting subjects’ ages at cohort entry to report higher NO2 
HRs for all-cause, cardiovascular, and respiratory mortality 
compared with cohorts with much broader age ranges upon 
entry. This observation, based upon a small number of stud-
ies, may be a chance finding. Alternatively, age at cohort entry 
may be correlated with smoking status and disease status as 
well as NO2 concentrations and proximity to traffic; further 
work is required to better understand this potentially impor-
tant effect modifier.
In recent years, a number of studies have used admin-
istrative databases to construct retrospective cohorts.25,26,31,36 
“Administrative” cohorts tend to use very large numbers of 
subjects with broad population coverage. They may lack indi-
vidual measures of potential confounders, e.g., smoking status 
and BMI utilizing instead small area measures derived from 
other sources. Residual confounding is generally acknowl-
edged as a potential weakness in these studies and investiga-
tors have attempted to evaluate this using statistical methods 
or survey data.26,36 Our stratified meta-analyses, separating 
studies with individual measures of smoking status and BMI 
from those who did not, found smaller HRs in the former 
with lower confidence limits below 1 for all causes of death 
except from CHD. A number of explanations for this find-
ing are possible: (1) chance, the differences observed reflect-
ing the results of studies that happen to be available at the 
time of the review; (2) other confounders, the two groups of 
studies give different results because of differences between 
studies other than the BMI and smoking characterization; (3) 
measurement error related to different scales of measurement 
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of confounders and exposure estimates; and (4) adjustment 
for these potential confounders at the small area level does 
not provide adequate control compared with that provided by 
individual measures. A sensitivity analysis using the English 
CPRD cohort (Carey I.M., personal communication, 2016) 
found that adjustment for individual-level smoking status and 
BMI after adjustment for a small area-level marker of socio-
economic status attenuated the all-cause mortality HR by a 
further 15%. The possibility remains, therefore, that studies 
unable to control for key individual confounders may be over-
stating the size of the association between long-term NO2 and 
all-cause mortality.
Meta-analysis stratified by the spatial resolution of the 
modeled NO2 concentrations showed for all-cause and cardio-
vascular-related deaths, a trend toward larger HRs for cohorts 
that used land-use regression models capable of estimating 
NO2 concentrations at the subjects’ residential address com-
pared with other pollution models that estimated concentra-
tions at a lower spatial resolution. This pattern was reversed 
for respiratory deaths. Such differences, though small, would 
have important implications for health impact assessments. 
Land-use regression models are capable of revealing gradients 
in NO2 concentrations that are missed by models that estimate 
concentrations for larger geographic areas. The improved pre-
cision of the estimate of a subject’s long-term exposure to a 
pollutant is achieved by reducing both systematic and random 
measurement error in the exposure estimate. Random mea-
surement error has long been acknowledged as a problem 
in epidemiological studies. If the estimated exposure can be 
expressed as a linear combination of the true exposure plus 
random error, that error is described as additive and “clas-
sical” but if the true exposure can be expressed as a linear 
combination of the estimated exposure plus random error, the 
error is described as additive and Berkson. Additive classical 
error leads on average to the underestimation of hazard ratios 
(bias towards the null), whereas Berkson error leads to wider 
confidence intervals due to reduced statistical power. Mea-
surement error introduced by spatial smoothing behaves like 
Berkson error whereas error introduced by parameter estima-
tion behaves like classical error.72,73 Thus, even if greater spa-
tial resolution in modeled NO2 concentrations results in more 
precise exposure estimates (i.e., less measurement error), the 
effect on hazard ratio estimation will depend on whether it is 
the overall Berkson or the classical component of measure-
ment error that is reduced.72 Hence, it does not follow nec-
essarily that land-use regression models will suffer less from 
bias toward the null than models with coarser spatial resolu-
tion. Of the six studies that used land-use regression models 
to estimate NO2 concentrations (Figure 2B), three administra-
tive cohorts dominated the meta-analysis (combined weight 
>69%). These three studies were also limited in their ability 
to control for individual measures of BMI and smoking and 
accounted for over 94% of the weight in the meta-analysis of 
studies with limited control for confounders (Figure 2A), and 
therefore, one should be cautious in the interpretation of these 
findings.
The calculation and use of prediction intervals in meta-
analyses has been advocated.13,68 In a random-effects model, 
study HRs are assumed to follow a distribution. The 95% CI 
for the summary HR represents, therefore, the range within 
which the mean of this distribution lies. It does not convey the 
uncertainty in the HR from any one study. A prediction inter-
val allows for the fact that the health effects of NO2 may differ 
from one setting to another (e.g., due to the susceptibility of 
the underlying population; the assessment of NO2 concentra-
tions; the pollutant mixture; underlying disease prevalence; 
competing risk factors; model specification etc.). It provides 
an appropriate indication of the precision of the estimated HR 
in a future setting.68 Given the sensitivity of health impact cal-
culations to small changes in the magnitude of the HR and 
the imprecision inherent in any meta-analyses of HRs, subse-
quent impact calculations should utilize prediction intervals 
and report ranges of impact rather than focusing upon point 
estimates.
Evidence gathered from experimental studies in ani-
mals and human volunteers and from epidemiologic studies 
employing biomarkers of effects of exposure to air pollutants 
offers limited support for the assertion that long-term expo-
sure to NO2 is causally associated with an increase in risk of 
death.7,8 Such evidence as there is for toxicological effects 
of NO2 on mortality comes largely from studies of the asso-
ciation with short-term exposure. These studies have, so far, 
provided no means of distinguishing the effects of NO2 from 
those of PM: both might well act via the same mechanisms 
including the induction of increased levels of oxidative free 
radicals and inflammation. Evidence for effects on the cardio-
vascular system, e.g., effects on levels of clotting factors and 
on the rate of progression of arterial disease, is better devel-
oped for PM than for NO2.
Only a small number of the studies identified in our 
review reported HRs for NO2 adjusted for PM. In some studies 
the correlation between pollutants was high (>0.8) limiting their 
ability to disentangle associations between the pollutants and 
mortality. The difficulties in interpreting coefficients in mul-
tipollutant models have received attention.74,75 These difficul-
ties include (1) correlation between pollutants (arising due to 
common sources and meteorologic conditions), which can lead 
to unstable parameter estimation; (2) differential measurement 
error between pollutants which can lead to the “transfer” of an 
association from the less well-measured (but true) pollutant to 
the better-measured (but incorrect) pollutant; and (3) statistical 
models which do not generally assess interactions between pol-
lutants in order to interpret correctly model main effects. Statis-
tical methods for dealing with correlated predictors have been 
proposed as well as the use of combined pollutant estimates 
to be used in formulating a multipollutant approach to regula-
tory policy.74,75 Given the current limited evidence base and the 
statistical issues described, it remains infeasible to distinguish 
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associations between NO2 and mortality from those for PM, 
especially fine particles arising from vehicle exhaust.
Previous reviews of both the toxicologic and epide-
miologic literature have concluded that the evidence was not 
sufficient to infer a causal relationship between long-term 
exposure to NO2 and mortality.
7,8 This caution was due in 
part to a lack of consistency in study findings and concerns 
relating to potential confounding by copollutants especially 
particles in traffic exhaust. Our study confirms the need for 
continued caution in respect of causality particularly since the 
revised meta-analyses suggest HRs close to one, with the pos-
sibility of further attenuation if meta-analyses are restricted to 
studies with individual measures of BMI and smoking. The 
substantial heterogeneity between study results also weakens 
the argument for causality. Unlike particles where unit mass 
concentrations might vary between locations in size, composi-
tion, and nature (primary/secondary), a unit mass concentra-
tion of NO2 gas is the same everywhere. We therefore consider 
that as the evidence stands at present, the causal basis for esti-
mating the burden of NO2 on mortality and loss of life expec-
tancy remains weak.
Our study found positive associations between long-
term concentrations of NO2 and risk of mortality from a range 
of diseases. However, there was substantial heterogeneity 
between estimates and evidence of differences in the mag-
nitude and precision of HRs depending upon the degree of 
control for individual confounding factors and the spatial reso-
lution of the NO2 concentration estimates. This has important 
implications for the selection of HRs for use in health impact 
assessment calculations. Given the many uncertainties inherent 
in the assessment of this evidence base and the sensitivity of 
health impact calculations to small changes in the magnitude 
of the HR, subsequent impact calculations should take account 
of these issues by utilizing prediction intervals and reporting 
ranges of impact rather than focusing upon a point estimate.
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